AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancyMegan V. Astle, Richard B. Pearson|Oncogene|2011Cited by 284
Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian CancersÅslaug Helland, David D.L. Bowtell, Michael S. Anglesio et al.|PLoS ONE|2011Cited by 219
First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation StudyAmit Khot, Simon J. Harrison, Karen E. Sheppard et al.|Cancer Discovery|2019Cited by 201
A functional genetic screen defines the AKT-induced senescence signaling networkKeefe T. Chan, Richard B. Pearson|Cell Death and Differentiation|2019Cited by 68
Reprogrammed <scp>mRNA</scp> translation drives resistance to therapeutic targeting of ribosome biogenesisEric Kusnadi, Richard B. Pearson|The EMBO Journal|2020Cited by 31